The Allergy Mom® Melissa Scheichl Provides Education and Support
Growing up Melissa Scheichl (aka The Allergy Mom®) of the Greater Toronto Area of Ontario, Canada, had both seasonal and food allergies and her mother suffered a dangerous anaphylactic reaction to a bee sting. As challenging and scary as these experiences were, however, allergies did not become a major focus of her life until her children were born almost 16 and 14 years ago. Read the article here.
Just in time for back to school, your Allergy Advocacy Association helped to score yet another win in New York State to better protect all our children with life-threatening allergies. When every second counts during an attack of anaphylaxis, school bus drivers will now be permitted to administer epinephrine. And before you hear that wonderful sound of the bus arriving on your child’s first day, make sure you have connected with the school nurse, teacher, building principal and coaches to inform them of your child’s allergies and what to do in an emergency. We wish you a healthy, happy school year!
We are very grateful for the leadership role Assemblyman David Buchwald (D-Westchester) and Senator Terence Murphy (R-Westchester) took in helping to pass legislation permitting school bus drivers and other school service providers to administer epinephrine in an emergency. And many thanks go to Gov. Andrew Cuomo for signing the bill so promptly. Now it is up to the New York State Department of Health to move quickly to issue the regulations necessary for timely implementation. We sincerely believe this legislation will help to save many lives over the years. You can read the full article here.
Allows Drivers and Others to Administer Life Saving Epinephrine
Adapted from a press release issued by Assemblyman David Buchwald with additional reporting by Jon Terry August 22, 2017
Governor Andrew Cuomo has signed legislation sponsored by Assemblyman David Buchwald (D-Westchester) to allow school bus drivers and other contractors providing services to schools to administer epinephrine when a child suffers anaphylaxis shock.
It was wonderful that the Emergency Allergy Treatment Act (EATA) was passed last September, enabling New York State’s public facilities to stock and administer epinephrine. This will be especially important to day care centers, where young children can have undiagnosed allergies to food or insect stings. While many centers are taking advantage of training provided by the Child Care Council of Rochester, they will have to come up with their own funding in order to purchase EpiPens. If you know of a business or foundation that might be willing to make a charitable donation for this important purpose, please let us know. You can read the full article here.
Emergency Allergy Treatment Act Becomes a Reality
By Janet Goldman
August 22, 2017
There is an old saying that goes something like this: “Children are the most precious of all” (author unknown). Due to our economy’s demands, countless children spend many hours in day care centers. With trust, parents choose these centers, expecting quality attention. To better ensure safety for those with life-threatening allergies, parents provide epinephrine auto-injectors. But what about protecting those that don’t know they are at risk?
38.7% of children with food allergies have had severe reactions(statistic from AAAAI). According to one survey (Snack Safely, 10/26/15, Dave Bloom) in the 2013/2014 school year, 22% of the anaphylactic cases were experienced by students who didn’t have an allergy history. Consequently, public facilities need to consider stocking epinephrine for their communities’ safety.
Last September, Governor Andrew Cuomo signed the Emergency Allergy Treatment Act (EATA), enabling New York State’s public facilities to take such safety measures. This past March, New York’s Health Department designed a policy supporting the new legislation. Also in March, New York’s Office of Children and Family Services (OCFS) arranged a health care plan, providing guidance to day care centers for implementing EATA.
Researchers in Australia have come up with a new therapy for peanut allergies that combines probiotics with small doses of peanuts to gradually train the child’s immune systems to not treat it as something foreign. The results are encouraging, allowing the children who were treated to eat peanuts without fear of an allergic reaction. But it may be too early to call this a cure.
In a long-term study of the latest treatment for peanut allergy, scientists in Australia report that an immune-based therapy helped children allergic to peanuts eat them without reactions for four years.